妊娠对危地马拉Tdap疫苗百日咳抗体纵向应答的影响
在危地马拉母亲Tdap疫苗接种临床试验中,比较30名未孕女性与156名孕妇的抗体应答。两组接种前各抗原抗体浓度相近,接种后2个月两组抗体均升高且未孕女性更高,至9个月抗体衰减后组间无差异。结果支持每次妊娠均接种Tdap的现有推荐。
要点
- 孕妇与未孕女性接种前抗体水平相近,接种后2个月均升高。
- 接种后2个月未孕女性疫苗抗原抗体浓度高于孕妇。
- 至9个月抗体衰减,两组间不再有差异。
核心结论
- 妊娠会影响Tdap接种后早期抗体应答,但9个月时组间差异消失,支持每次妊娠接种Tdap的推荐。
研究设计与样本
- 在危地马拉母亲Tdap疫苗接种临床试验中,比较30名未孕女性与156名孕妇的纵向抗体应答。
主要发现
- 两组接种前所有疫苗抗原抗体浓度相似;接种后2个月两组抗体均升高,未孕女性更高;9个月时抗体衰减且组间无差异。
临床怎么用
- 维持每次妊娠接种Tdap的现有推荐;在母亲Tdap覆盖率低的环境可考虑为未孕女性接种。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Maternal immunization with tetanus, diphtheria, and acellular pertussis (Tdap) vaccine is recommended in many countries, but coverage in many low-income countries remains suboptimal. Targeted vaccination of women of child-bearing age could be a supplemental strategy to address this gap, but there are limited longitudinal immunogenicity data in this population outside of high-income countries. We compared antibody responses to Tdap between 30 non-pregnant women and 156 pregnant women enrolled in a clinical trial of maternal Tdap vaccination in Guatemala. Pre-vaccination antibody concentrations among both groups were similar for all vaccine antigens. At 2 months post-vaccination, antibody concentrations against vaccine antigens increased in both groups and were higher among non-pregnant women. By 9 months, antibody concentrations had decayed and were no longer different by study group. These findings reinforce existing recommendations for Tdap vaccination with every pregnancy. Vaccination of non-pregnant women may be considered in settings where maternal Tdap coverage is low.
引用
- Phadke VK, Bednarczyk RA, Maldonado H, et al. Impact of pregnancy on longitudinal pertussis antibody responses to Tdap vaccine in Guatemala. Vaccine. 2025. PMID: 41422788. doi:10.1016/j.vaccine.2025.128134
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。